Goal

Optogenerapy aims to develop and demonstrate a new optogenetics implant for controlled beta interferon (IFN- ß) protein delivery for treating patients suffering from multiple sclerosis

Are you a clinician?

We are looking for clinicians working on Multiple Sclerosis willing to participate in the project by providing their feedback on Optogenerapy’s medical device by answering a short survey via email or telephone call. Your feedback will be considered by project partners and integrated, when possible, during the project development.

 

Interested clinicians will be also invited to Optogenerapy’s clinical training workshops, aiming at presenting the implant to the medical professional community and enriching the clinical know-how.

Contact us

    I am interested in providing feedback to Optogenerapy project (*required)

    Impact

    For Patients

    Improve drug effectiveness
    Improve compliance with drug taking

    For System

    Reduce direct and indirect costs
    linked to Multiple Sclerosis

    For Society

    Social awareness of efficient therapies
    improving patient compliance

    Partners

    eth_zurich
    politechnika
    erasmus
    genexplan
    ase-optics
    neos_surgery
    ultrasion
    inserm
    une
    Do NOT follow this link or you will be banned from the site!